Analysts Set Cabot Co. (NYSE:CBT) Target Price at $87.67

Cabot Co. (NYSE:CBTGet Free Report) has received an average recommendation of “Hold” from the five research firms that are presently covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $90.17.

CBT has been the subject of several analyst reports. Mizuho initiated coverage on shares of Cabot in a report on Wednesday, March 27th. They set a “buy” rating and a $104.00 price target for the company. UBS Group cut shares of Cabot from a “buy” rating to a “neutral” rating and cut their target price for the company from $90.00 to $87.00 in a research note on Monday, January 8th. Deutsche Bank Aktiengesellschaft lowered Cabot from a “buy” rating to a “hold” rating and increased their price target for the stock from $88.00 to $95.00 in a research report on Thursday, April 18th. Finally, StockNews.com cut Cabot from a “strong-buy” rating to a “buy” rating in a report on Wednesday, February 14th.

Read Our Latest Research Report on CBT

Insiders Place Their Bets

In other news, EVP Jeff Ji Zhu sold 55,233 shares of Cabot stock in a transaction on Tuesday, February 13th. The stock was sold at an average price of $79.91, for a total value of $4,413,669.03. Following the completion of the sale, the executive vice president now directly owns 97,201 shares of the company’s stock, valued at approximately $7,767,331.91. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 3.07% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Norges Bank bought a new stake in shares of Cabot during the fourth quarter worth approximately $41,471,000. Sei Investments Co. raised its position in shares of Cabot by 33.9% during the 4th quarter. Sei Investments Co. now owns 812,614 shares of the specialty chemicals company’s stock valued at $67,854,000 after acquiring an additional 205,582 shares during the last quarter. Envestnet Asset Management Inc. lifted its stake in shares of Cabot by 92.7% in the 3rd quarter. Envestnet Asset Management Inc. now owns 288,216 shares of the specialty chemicals company’s stock valued at $19,965,000 after purchasing an additional 138,663 shares during the period. AQR Capital Management LLC lifted its stake in shares of Cabot by 350.6% in the 3rd quarter. AQR Capital Management LLC now owns 176,452 shares of the specialty chemicals company’s stock valued at $12,223,000 after purchasing an additional 137,294 shares during the period. Finally, Eventide Asset Management LLC bought a new position in shares of Cabot in the 4th quarter worth $6,919,000. 93.18% of the stock is currently owned by institutional investors and hedge funds.

Cabot Trading Up 0.8 %

CBT stock opened at $92.72 on Thursday. Cabot has a 1-year low of $63.73 and a 1-year high of $98.34. The company has a current ratio of 2.04, a quick ratio of 1.30 and a debt-to-equity ratio of 0.74. The business’s 50 day moving average is $88.53 and its 200-day moving average is $80.00. The firm has a market cap of $5.14 billion, a P/E ratio of 12.04, a P/E/G ratio of 0.97 and a beta of 1.28.

Cabot (NYSE:CBTGet Free Report) last announced its quarterly earnings results on Monday, February 5th. The specialty chemicals company reported $1.56 earnings per share for the quarter, beating analysts’ consensus estimates of $1.49 by $0.07. Cabot had a return on equity of 25.52% and a net margin of 11.24%. The firm had revenue of $958.00 million for the quarter, compared to analysts’ expectations of $927.28 million. Equities analysts anticipate that Cabot will post 6.58 earnings per share for the current fiscal year.

Cabot Company Profile

(Get Free Report

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

See Also

Analyst Recommendations for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.